Maplelane Capital’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.81M Buy
+7,000
New +$2.58M 0.06% 121
2025
Q1
– Sell
-119,450
Closed -$15M – 130
2024
Q4
$15M Buy
+119,450
New +$14.1M 0.44% 53
2024
Q2
– Sell
-89,000
Closed -$10M – 111
2024
Q1
$10M Buy
+89,000
New +$9.27M 0.32% 61
2023
Q3
– Sell
-140,000
Closed -$15.6M – 69
2023
Q2
$15.6M Buy
+140,000
New +$14M 0.49% 43
2019
Q1
– Sell
-120,640
Closed -$4.51M – 167
2018
Q4
$3.78M Sell
120,640
-49,361
-29% -$1.67M 0.11% 91
2018
Q3
$6.29M Buy
+170,001
New +$6.85M 0.21% 81
2015
Q1
– Sell
-318,376
Closed -$6.3M – 228
2014
Q4
$6.3M Buy
+318,376
New +$6.01M 0.24% 90
2014
Q3
– Sell
-150,001
Closed -$2.94M – 170
2014
Q2
$2.94M Sell
150,001
-1,415,490
-90% -$26.3M 0.19% 86
2014
Q1
$31M Buy
1,565,491
+1,265,491
+422% +$24.5M 1.04% 25
2013
Q4
$5.29M Buy
+300,000
New +$5.07M 0.21% 86

Other funds holding TER

Maplelane Capital's TER Position: Q3 2026 in Review

Maplelane Capital opened a new position in Teradyne (TER) in Q3 2026: 7,000 shares worth $2.81M. The stake represents 0.06% of the portfolio and ranks #121 among its holdings. This is a return to the name: Maplelane Capital previously reported a position in TER as recently as Q4 2024.

Maplelane Capital first reported a position in TER in Q4 2013 and has held it in 10 quarters since. The position peaked at $31M in Q1 2014. 1,361 funds tracked by Wall St. Rank hold TER as of Q3 2026.

  • Maplelane Capital held 7,000 shares of Teradyne worth $2.81M as of Q3 2026.
  • Teradyne was a new Maplelane Capital position in Q3 2026.
  • Teradyne made up 0.06% of Maplelane Capital's portfolio in Q3 2026, its #121 holding.
  • Maplelane Capital first reported a position in Teradyne in Q4 2013 and has held it in 10 quarters since.
  • Maplelane Capital's Teradyne position peaked at $31M in Q1 2014.
  • 1,361 funds tracked by Wall St. Rank held Teradyne as of Q3 2026.

Based on Maplelane Capital's 13F filing for Q3 2026, filed 16 Nov 2026.